| __timestamp | PTC Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 94231000 |
| Thursday, January 1, 2015 | 121816000 | 146394000 |
| Friday, January 1, 2016 | 117633000 | 188272000 |
| Sunday, January 1, 2017 | 117456000 | 166707000 |
| Monday, January 1, 2018 | 171984000 | 401843000 |
| Tuesday, January 1, 2019 | 257452000 | 560909000 |
| Wednesday, January 1, 2020 | 477643000 | 722343000 |
| Friday, January 1, 2021 | 540684000 | 771182000 |
| Saturday, January 1, 2022 | 651496000 | 877090000 |
| Sunday, January 1, 2023 | 666563000 | 877387000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical breakthroughs.
From 2014 to 2023, Sarepta Therapeutics increased its R&D expenses by approximately 830%, peaking in 2023. This surge underscores their aggressive pursuit of new therapies, particularly in the field of genetic medicine. Meanwhile, PTC Therapeutics also ramped up its R&D spending by over 730% during the same period, highlighting their focus on rare disorders.
These investments are not just numbers; they represent a strategic commitment to innovation, with both companies striving to transform the future of healthcare. As they continue to allocate substantial resources to R&D, the biotech landscape is poised for exciting developments.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and PTC Therapeutics, Inc.
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.